Active Not RecruitingNCT05562349
Clavulanic acid or placebo for cocaine use
About this title
Clavulanic Acid for the Treatment of Cocaine Use Disorder
Read the official source — NCT05562349Medication studyAges 18–70United StatesAddiction
Understand this study
Who could participate?
Listed age limits: 18 years to 70 years.
- Listed locations
- Philadelphia and 1 more locationSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: May 3, 2023
- Recruitment status
- Active Not Recruiting
- Enrollment listed in the registry
- 65
- Sponsor
- Temple University
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 18 Years to 70 Years
- Official registry ID
- NCT05562349
- Official title
Show the full official title
A Randomized, Double-Blind, Placebo-Controlled Phase 2a Pilot Study to Assess the Efficacy and Safety of Clavulanic Acid vs. Placebo for the Treatment of Cocaine Use Disorder
Recruitment & locations
Not recruitingThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Philadelphia · Charleston
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Temple University, a university.
Does this study involve medication?
Yes. The study involves medication, including Clavulanic Acid Only Product and Placebo.
Who can participate?
Listed age limits: 18 years to 70 years.
Is this study still recruiting?
The registry lists this study as active, but no longer recruiting.
